Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

Clinical trial NCT07330245 · RECRUITING

Trial details

NCT number: NCT07330245
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Lupus Erythematosus, Systemic

Start date: 2025-12-31
Primary completion: 2028-09-30
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.